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TO THE EDITOR
The Gram-positive bacterium Staphylo-
coccus aureus is an important pathogen
that causes various skin infections
(Miller and Kaplan, 2009). However,
healthy skin is usually not infected by
S. aureus, despite the high carrier rates
in the normal population (Noble,
1998). This suggests that the cutaneous
defense system has the capacity to
effectively control the growth of S.
aureus. There is increasing evidence
that antimicrobial proteins are impor-
tant effectors of the cutaneous defense
system (Harder et al., 2007). A recent
study reported that keratinocytes con-
tribute to cutaneous innate defense
against S. aureus through the produc-
tion of human b-defensin-3 (Kisich
et al., 2007). In addition to human b-
defensin-3,, other antimicrobial pro-
teins may also participate in cutaneous
defense against S. aureus. One candi-
date is RNase 7, a potent antimicrobial
ribonuclease that is highly expressed in
healthy skin (Harder and Schro¨der,
2002; Ko¨ten et al., 2009).
To investigate the hypothesis that
RNase 7 may contribute to protect
healthy skin from S. aureus coloniza-
tion, we first incubated natural RNase 7
isolated from stratum corneum skin
extracts (Harder and Schro¨der, 2002)
with S. aureus (ATCC 6538). In con-
cordance with our initial report about
RNase 7 (Harder and Schro¨der, 2002),
we verified that RNase 7 exhibited
a high killing activity against S. aureus
(lethal dose of 90% ¼3–6 mg ml1).
Recently, we reported a moderate
induction of RNase 7 mRNA expres-
sion in primary keratinocytes treated
with heat-killed S. aureus (Harder and
Schro¨der, 2002). To assess the induc-
tion of RNase 7 by S. aureus in the
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Figure 1. Induced secretion of RNase 7 on the skin surface on treatment with living S. aureus.
Defined areas (0.8 cm2) of skin explants derived from plastic surgery were incubated with or without
approximately 1,000 colony-forming units of S. aureus (ATCC 6538) in 100 ml of sodium phosphate
buffer. After 2, 6, and 20 hours, the concentration of secreted RNase 7 was determined by ELISA.
Stimulation with S. aureus for 2 hours revealed a significant induction as compared with the
unstimulated control after 2 hours (*Po0.05, Student’s t-test; n.s.¼ not significant). Data shown are
means of triplicates of five skin explants derived from five donors.
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context of more physiological condi-
tions, we used human skin explants and
incubated them for 2, 6, and 20 hours
with living S. aureus (the use of skin
material for this study was approved by
the ethical committee of the University
Kiel (A 104/06) in accordance with
the Declaration of Helsinki Principles).
As shown in Figure 1, only 2 hours
of incubation with living S. aureus
significantly induced the secretion of
RNase 7 on the skin surface as mea-
sured by an RNase 7-specific ELISA
(Ko¨ten et al., 2009). This indicates a fast
release of preformed material. The
reduced secretion after 20 hours could
be a result of cytotoxic effects from
S. aureus, as well as of a decreased
viability of skin explants. Secretion of
RNase 7 after 2 hours was enhanced by
increasing concentrations of S. aureus
(Supplementary Figure S1 online).
To further assess the physiological
relevance of RNase 7 in cutaneous
defense against S. aureus, we investi-
gated whether the killing activity of skin
extracts derived from stratum corneum
was inhibited through blocking of the
antimicrobial activity of RNase 7 by
RNase 7-specific antibodies as pre-
viously described (Ko¨ten et al., 2009).
First, we analyzed whether RNase 7
antibodies neutralized the antibacterial
activity of RNase 7 against S. aureus.
For this purpose, we tested the activity
of RNase 7 against S. aureus in an
antibacterial microdilution assay in the
presence of RNase 7 antibodies. This
approach revealed that the application
of RNase 7 antibodies completely
blocked the S. aureus-killing activity
of RNase 7. In contrast, the antimicro-
bial activity was not inhibited when
equivalent concentrations of irrelevant
antibodies (derived from goat pre-
immune serum; Ko¨ten et al., 2009)
were used (data not shown). Having
established that RNase 7-specific anti-
bodies neutralized the antimicrobial
effect of RNase 7 against S. aureus,
we used this approach to test the
functional role of RNase 7 in cutaneous
defense against S. aureus. To this end,
we first incubated a stratum corneum
skin extract with S. aureus. The skin
extract was diluted to a ratio of 1:200
in 25 ml of sodium phosphate buffer (pH
7.4) without or with RNase 7-blocking
antibody (4 mg ml1) or an equivalent
concentration of an irrelevant antibody.
This dilution leads to a final concen-
tration of 6 mg ml1 RNase 7 in the
assay system, which corresponds to
the determined range of the lethal
dose90 of RNase 7 against S. aureus
(see above). After 45 minutes, 25 ml
of S. aureus (ATCC 6538) in sodium
phosphate buffer (pH 7.4) containing
2% tryptone soya broth was added and
incubated for 3 hours. Killing activity
was analyzed by plating serial dilutions
of the incubation mixture and determin-
ing colony-forming units the following
day. The skin extract exhibited a potent
S. aureus-killing activity, as incubation
of S. aureus with the skin extract resulted
in a complete killing of S. aureus (Figure
2a). The application of RNase 7-block-
ing antibodies to the skin extract before
inoculation with S. aureus resulted in an
outgrowth of S. aureus of approximately
35% as compared with the growth
control (Figure 2a). In contrast, an
irrelevant antibody did not inhibit
the killing activity of the skin extract
(Figure 2a). These data indicate an
important contribution of RNase 7 to
the S. aureus-killing activity of the skin
extracts. Other skin-derived antimicro-
bial proteins may be responsible for the
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Figure 2. RNase 7 contributes to the killing activity of human skin against S. aureus. (a) Stratum
corneum extracts were incubated without (subcutaneous (s.c.)) or with RNase 7-blocking antibody
(s.c.þR7-specific Ab) or an irrelevant antibody (s.c.þ irrelevant Ab). After 45 minutes, S. aureus was
added and colony-forming units (CFUs) were determined after 3 hours of incubation. Data shown are
means±SD of a representative result of three independent experiments. (b) Defined areas (0.8 cm2) of
skin explants were incubated without (skin control) or with RNase 7 antibody (skinþR7-specific Ab) or
with an equivalent concentration of an irrelevant antibody (skinþ irrelevant Ab). After 30 minutes,
S. aureus was added and CFU were determined after 2 hours of incubation. Data show means±SD
of triplicate experiments of the same donor. A representative result of three independent experiments
from three donors is shown. Student’s t-test was used for statistics.
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S. aureus-killing activity, which re-
mained after blocking the antimicrobial
activity of RNase 7.
To obtain additional insight into the
functional role of RNase 7 in cutaneous
defense against S. aureus, we studied
the role of RNase 7 using human
skin explants. In this experimental
ex vivo model, S. aureus was applied
to defined areas (0.8 cm2) of the surface
of skin explants. Preincubation of
skin samples with 1.5 mg ml1 RNase
7-blocking antibody in 100ml of
sodium phosphate buffer (pH 7.4)
led to a significant outgrowth of S.
aureus as compared with pretreatment
of skin with an equivalent concentra-
tion of irrelevant antibody (Figure 2b).
These data further indicate a physiolo-
gical relevance of RNase 7 for the
control of S. aureus growth on the skin
surface.
In summary, data present herein
show that skin infected with living
S. aureus responds with an increased
release of RNase 7, which contributes
to limit the growth of S. aureus. These
data are in concordance with a recently
published study reporting that lower
RNase 7 expression in healthy skin is
associated with a higher risk of
S. aureus skin infection (Zanger et al.,
2009). Future studies have to evaluate
whether skin infections caused by
S. aureus may be associated with an
impaired expression or function of
RNase 7.
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TO THE EDITOR
Bullous pemphigoid (BP) is a rare,
usually severe and potentially life-
threatening disease. Immunologically,
this disorder is characterized by the
presence of circulating IgG autoanti-
bodies targeting distinct adhesion mole-
cules of the dermoepidermal basement
membrane zone (Hertl, 2000). Binding
of autoantibodies to adhesion structures
of the skin leads to a massive loss of
function, resulting in blister formation.
The majority of BP patients possesses
high-affinity IgG autoantibodies directed
against the 180 kDa BP autoantigen
(BP180; Diaz et al., 1990). The immu-
nodominant site of BP180 is located
within the short NC16a domain, which
is recognized by more than 90% of BP
patients. In the previous studies we have
identified the presence of memory B
cells specific for the NC16a domain,
which can be induced in vitro to
synthesize autoantibodies (Leyendeckers
et al., 2003). Also, it was shown that the
serum level of autoantibodies to NC16a
correlates with the severity of BP
(Schmidt et al, 2000). The bulk of
antibodies measurable in the serum are
synthesized by terminally differentiated
B lymphocytes, that is, plasma cells
(PCs), mostly residing in the boneAbbreviations: BP, bullous pemphigoid; BM, bone marrow; PB, plasma blast; PC, plasma cell
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